secwatch.observer — SEC 8-K summary
======================================

Issuer:     Phreesia, Inc. (PHR)
CIK:        0001412408
Form:       8-K
Filed at:   2023-03-22T23:59:59+00:00
Accession:  0001412408-23-000017
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Phreesia Q4 FY2023 revenue $76.6M (+32% YoY); FY2024 guidance revenue $353-356M
-------------------------------------------------------------------------------

- Q4 revenue $76.6M (+32% YoY); net loss $38.0M vs $46.5M loss year ago; Adj. EBITDA -$17.6M vs -$30.5M.
- AHSCs 3,140 (+36% YoY); Healthcare services revenue per AHSC $17,705 (-4% YoY).
- Full year revenue $280.9M (+32%); net loss $176.1M vs $118.2M prior year; Adj. EBITDA -$92.5M.
- FY2024 outlook: revenue $353-356M (26-27% growth); Adj. EBITDA loss -$65M to -$60M (improvement).
- Cash $176.7M at Jan 31; transferred funds from SVB on March 9 before FDIC receivership; all cash available.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1412408/000141240823000017/0001412408-23-000017-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1412408/000141240823000017/phr-20230322.htm
  HTML page:      https://secwatch.observer/filing/0001412408-23-000017

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer